🇺🇸 FDA
Pipeline program

ABI-5366

ABI-5366-101

Phase 1 small_molecule completed

Quick answer

ABI-5366 for Recurrent Genital Herpes Simplex Type 2 is a Phase 1 program (small_molecule) at ASSEMBLY BIOSCIENCES, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
ASSEMBLY BIOSCIENCES, INC.
Indication
Recurrent Genital Herpes Simplex Type 2
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials